Results 51 to 60 of about 91,699 (304)

Perbandingan Tingkat Keparahan Infeksi Sekunder Virus Dengue pada Keempat Serotipe di Indonesia: Systematic Review

open access: yesJurnal Kesehatan Andalas, 2021
Secondary infection with the dengue virus causes mild to severe manifestations. The distribution of dengue virus serotypes varies in various areas and can change over time.
Annelin Kurniati   +4 more
doaj   +1 more source

Factors associated with severe dengue in patients from Cauca, Colombia, 2015–2021

open access: yesIatreia
Introduction: The department of Cauca, Colombia, is endemic for dengue fever. The prevalence of severe dengue has consistently exceeded national indicators, highlighting the critical importance of appropriate and timely classification and treatment of ...
Bolaños-Díaz, María Cristina   +3 more
doaj   +1 more source

Zika virus: New clinical syndromes and its emergence in the western hemisphere [PDF]

open access: yes, 2016
Zika virus (ZIKV) had remained a relatively obscure flavivirus until a recent series of outbreaks accompanied by unexpectedly severe clinical complications brought this virus into the spotlight as causing an infection of global public health concern.
Brazilian Medical Genetics Society–Zika Embryopathy Task Force   +9 more
core   +3 more sources

Assessing the risk of dengue severity using demographic information and laboratory test results with machine learning.

open access: yesPLoS Neglected Tropical Diseases, 2020
BackgroundDengue virus causes a wide spectrum of disease, which ranges from subclinical disease to severe dengue shock syndrome. However, estimating the risk of severe outcomes using clinical presentation or laboratory test results for rapid patient ...
Sheng-Wen Huang   +4 more
doaj   +1 more source

Chimeric Yellow Fever/Dengue Virus as a Candidate Dengue Vaccine: Quantitation of the Dengue Virus-Specific CD8 T-Cell Response [PDF]

open access: yes, 2000
We have constructed a chimeric yellow fever/dengue (YF/DEN) virus, which expresses the premembrane (prM) and envelope (E) genes from DEN type 2 (DEN-2) virus in a YF virus (YFV-17D) genetic background. Immunization of BALB/c mice with this chimeric virus
Ahmed, Rafi   +3 more
core   +2 more sources

Nano‐ and Micro‐Sized Solid Materials Used as Antiviral Agents

open access: yesAdvanced Functional Materials, EarlyView.
Due to the rise of viral infections in humans and possible viral outbreaks, the use of nano‐ or micro‐sized materials as antiviral agents is rapidly increasing. This review explores their antiviral properties against RNA and DNA viruses, either as a prevention or a treatment tool, by delving into their mechanisms of action and how to properly assess ...
Orfeas‐Evangelos Plastiras   +6 more
wiley   +1 more source

A comparison of WHO guidelines issued in 1997 and 2009 for dengue fever - single centre experience. [PDF]

open access: yes, 2013
Objective: To compare the original (1997) and revised (2009) versions of World Health Organization guidelines for dengue patientsMethods: Adult patients with a positive dengue Immunoglobulin M serology, and a diagnosis of dengue were included in the ...
Ejaz, Kiran   +5 more
core   +1 more source

Specific detection of dengue and Zika virus antibodies using envelope proteins with mutations in the conserved fusion loop [PDF]

open access: yes, 2017
Detection of antibodies is widely used for the diagnosis of infections with arthropod-borne flaviviruses including dengue (DENV) and Zika virus (ZIKV). Due to the emergence of ZIKV in areas endemic for DENV, massive co-circulation is observed and methods
Barzon, Luisa   +12 more
core   +2 more sources

Daily Dengue Severity Score to Assess Severe Manifestations

open access: yesPediatric Infectious Disease Journal, 2020
Background: The study aimed to develop dengue severity score to assess severe manifestations among hospitalized patients with dengue infection. Method: Children and adolescents with serologically confirmed dengue infection admitted at Ramathibodi Hospital from 2004 to 2018 and ...
Kanchana, Tangnararatchakit   +6 more
openaire   +3 more sources

Evaluating the Antiviral Efficacy of Encapsulated PKC Inhibitor BIM‐I against influenza A Virus Infection

open access: yesAdvanced Healthcare Materials, EarlyView.
This study explores nanoparticle delivery of the protein kinase C inhibitor bisindolylmaleimide‐I (BIM‐I) to combat influenza A virus infections. Encapsulation in biodegradable PLGA nanoparticles improved safety while maintaining the compound's strong antiviral activity.
Laura Klement   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy